Steve N. Slilaty - 18 Feb 2022 Form 4 Insider Report for Sunshine Biopharma, Inc (SBFM)

Role
Chief Executive Officer, Director
Signature
/s/ Steve N. Slilaty
Issuer symbol
SBFM
Transactions as of
18 Feb 2022
Net transactions value
-$99,000
Form type
4
Filing time
22 Feb 2022, 12:07:24 UTC
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBFM Series B Preferred Stock Disposed to Issuer $99,000 -990,000 -99% $0.1000 10,000 18 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Slilaty returned 990,000 shares of Series B Preferred Stock to the Issuer for a redemption price equal to the stated value of $0.10 per share.